Reversible permeabilization of plasma membranes with an engineered switchable pore.
By using an engineered, self-assembling, proteinaceous, 2-nm pore equipped with a metal-actuated switch, a technique to reversibly permeabilize the plasma membrane to small molecules (approximately 1000 Da) has been developed. We have demonstrated the dose-dependent permeabilization of fibroblasts by pores designed to be blocked and unblocked by the addition and removal of microM concentrations of Zn2+. Further, we have shown that the activity of the switch allows permeabilized cells to maintain viability and ultrastructural integrity following the unconstrained flux of small molecules. This ability to control the transmembrane influx and efflux of molecules and thereby vary the intracellular environment yet maintain cell viability will impact an array of biological and medical problems.
Russo
M J
MJ
Center for Engineering in Medicine, Massachusetts General Hospital, Boston 02114, USA.
Bayley
H
H
Toner
M
M
D016475:3T3 Cells; D000818:Animals; D001427:Bacterial Toxins / Q000235:genetics / Q000494:pharmacology; D001692:Biological Transport; D002463:Cell Membrane Permeability / Q000187:drug effects*; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D006460:Hemolysin Proteins / Q000235:genetics / Q000494:pharmacology; D051379:Mice; D008854:Microscopy, Electron; D016296:Mutagenesis; D013395:Sucrose / Q000378:metabolism; D015032:Zinc / Q000494:pharmacology
D001427:Bacterial Toxins; D006460:Hemolysin Proteins; C021091:staphylococcal alpha-toxin; D013395:Sucrose; D015032:Zinc